132 related articles for article (PubMed ID: 35972550)
1. CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging.
O'Malley RB; Cox D; Soloff EV; Zečević M; Green S; Coveler A; Busey JM; Wang CL
Abdom Radiol (NY); 2022 Nov; 47(11):3770-3781. PubMed ID: 35972550
[TBL] [Abstract][Full Text] [Related]
2. Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience.
Hamdy A; Ichikawa Y; Toyomasu Y; Nagata M; Nagasawa N; Nomoto Y; Sami H; Sakuma H
Radiology; 2019 Sep; 292(3):628-635. PubMed ID: 31287389
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma.
O'Malley RB; Soloff EV; Coveler AL; Cox DH; Desai N; Busey JM; Valentin GM; Wang CL
Abdom Radiol (NY); 2021 May; 46(5):1992-2002. PubMed ID: 33079256
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
5. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
[No Abstract] [Full Text] [Related]
6. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
Amer AM; Zaid M; Chaudhury B; Elganainy D; Lee Y; Wilke CT; Cloyd J; Wang H; Maitra A; Wolff RA; Varadhachary G; Overman MJ; Lee JE; Fleming JB; Tzeng CW; Katz MH; Holliday EB; Krishnan S; Minsky BD; Herman JM; Taniguchi CM; Das P; Crane CH; Le O; Bhosale P; Tamm EP; Koay EJ
Cancer; 2018 Apr; 124(8):1701-1709. PubMed ID: 29370450
[TBL] [Abstract][Full Text] [Related]
7. Computed Tomography Perfusion Analysis of Pancreatic Adenocarcinoma using Deconvolution, Maximum Slope, and Patlak Methods - Evaluation of Diagnostic Accuracy and Interchangeability of Cut-Off Values.
Koell M; Klauss M; Skornitzke S; Mayer P; Fritz F; Stiller W; Grenacher L
Rofo; 2021 Sep; 193(9):1062-1073. PubMed ID: 33772484
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Borhani AA; Dewan R; Furlan A; Seiser N; Zureikat AH; Singhi AD; Boone B; Bahary N; Hogg ME; Lotze M; Zeh HJ; Tublin ME
AJR Am J Roentgenol; 2020 Feb; 214(2):362-369. PubMed ID: 31799875
[No Abstract] [Full Text] [Related]
9. Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth.
Mayer P; Fritz F; Koell M; Skornitzke S; Bergmann F; Gaida MM; Hackert T; Maier-Hein K; Laun FB; Kauczor HU; Grenacher L; Klauß M; Stiller W
Cancer Imaging; 2021 Jan; 21(1):13. PubMed ID: 33468259
[TBL] [Abstract][Full Text] [Related]
10. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
[TBL] [Abstract][Full Text] [Related]
11. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.
Bellomi M; Petralia G; Sonzogni A; Zampino MG; Rocca A
Radiology; 2007 Aug; 244(2):486-93. PubMed ID: 17641369
[TBL] [Abstract][Full Text] [Related]
12. Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review.
Perik TH; van Genugten EAJ; Aarntzen EHJG; Smit EJ; Huisman HJ; Hermans JJ
Abdom Radiol (NY); 2022 Sep; 47(9):3101-3117. PubMed ID: 34223961
[TBL] [Abstract][Full Text] [Related]
13. Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.
Rana L; Sharma S; Sood S; Singh B; Gupta MK; Minhas RS; Jhobta A; Bhatia V; Venkat B
Eur J Radiol Open; 2015; 2():46-54. PubMed ID: 26937435
[TBL] [Abstract][Full Text] [Related]
14. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
[TBL] [Abstract][Full Text] [Related]
15. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
Cheng SH; Cheng YJ; Jin ZY; Xue HD
Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
[TBL] [Abstract][Full Text] [Related]
16. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
[No Abstract] [Full Text] [Related]
17. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects.
Fraioli F; Anzidei M; Serra G; Liberali S; Fiorelli A; Zaccagna F; Longo F; Anile M; Catalano C
Br J Radiol; 2013 Sep; 86(1029):20120174. PubMed ID: 23908346
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging.
Xu J; Liang Z; Hao S; Zhu L; Ashish M; Jin C; Fu D; Ni Q
Abdom Imaging; 2009 Nov; 34(6):759-66. PubMed ID: 19672566
[TBL] [Abstract][Full Text] [Related]
19. Perfusion CT - Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum?
Yadav AK; Sharma R; Kandasamy D; Pradhan RK; Garg PK; Bhalla AS; Gamanagatti S; Srivastava DN; Sahni P; Upadhyay AD
Pancreatology; 2016; 16(6):979-987. PubMed ID: 27568845
[TBL] [Abstract][Full Text] [Related]
20. Perfusion CT - A novel quantitative and qualitative imaging biomarker in gastric cancer.
Kruk-Bachonko J; Krupski W; Czechowski M; Kurys-Denis E; Mądro P; Sierocińska-Sawa J; Dąbrowski A; Wallner G; Skoczylas T
Eur J Radiol; 2017 Oct; 95():399-408. PubMed ID: 28987697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]